IL7 and type 1 diabetes mellitus: Other diseases with metabolic alterations, such as autoimmune diabetes, have exhibited high serum sCD127 concentrations at the onset of type 1 diabetes [38], showing that metabolic factors may contribute to dysregulation of the IL-7/IL-7 receptor pathway.